Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al V Taira

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Emerging Infectious Diseases|January 21, 2003
Cost-effectiveness of a potential vaccine for human papillomavirusGillian D Sanders, Al V Taira
Emerging Infectious Diseases|November 20, 2004
Evaluating human papillomavirus vaccination programsAl V Taira, Christopher P Neukermans, Gillian D Sanders
Radiology|March 30, 2007
Detection of bone metastases: assessment of integrated FDG PET/CT imagingAl V Taira, Robert J Herfkens, Sam S Gambhir, et al.
American Journal of Clinical Oncology|October 15, 2016
Impact of Androgen Deprivation Therapy on Overall Mortality in Prostate Brachytherapy Patients With Low Pretreatment Testosterone LevelsAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2009
Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Brachytherapy|October 31, 2009
Factors impacting all-cause mortality in prostate cancer brachytherapy patients with or without androgen deprivation therapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Journal of Contemporary Brachytherapy|October 23, 2014
Metformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2012
Prognostic importance of small prostate size in men receiving definitive prostate brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Brachytherapy|March 12, 2013
Impact of small prostate size on postimplant prostate dosimetry: analysis of a large community databaseAl V Taira, Gregory S Merrick, Peter Grimm, et al.
BJU International|March 6, 2010
Relationship between prostate cancer mortality and number of unfavourable risk factors in men treated with definitive brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Emerging Infectious Diseases|January 21, 2003
Cost-effectiveness of a potential vaccine for human papillomavirusGillian D Sanders, Al V Taira
Emerging Infectious Diseases|November 20, 2004
Evaluating human papillomavirus vaccination programsAl V Taira, Christopher P Neukermans, Gillian D Sanders
Radiology|March 30, 2007
Detection of bone metastases: assessment of integrated FDG PET/CT imagingAl V Taira, Robert J Herfkens, Sam S Gambhir, et al.
American Journal of Clinical Oncology|October 15, 2016
Impact of Androgen Deprivation Therapy on Overall Mortality in Prostate Brachytherapy Patients With Low Pretreatment Testosterone LevelsAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2009
Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Brachytherapy|October 31, 2009
Factors impacting all-cause mortality in prostate cancer brachytherapy patients with or without androgen deprivation therapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Journal of Contemporary Brachytherapy|October 23, 2014
Metformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2012
Prognostic importance of small prostate size in men receiving definitive prostate brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Brachytherapy|March 12, 2013
Impact of small prostate size on postimplant prostate dosimetry: analysis of a large community databaseAl V Taira, Gregory S Merrick, Peter Grimm, et al.
BJU International|March 6, 2010
Relationship between prostate cancer mortality and number of unfavourable risk factors in men treated with definitive brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Pageof 3